Bodycote (LON:BOY – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Jefferies Financial Group in a research note issued on Wednesday,Digital Look reports. They currently have a GBX 900 price target on the stock. Jefferies Financial Group’s price target points to a potential upside of 30.81% from the stock’s current price.
Several other research firms have also recently weighed in on BOY. Royal Bank Of Canada reiterated a “sector perform” rating and set a GBX 750 price objective on shares of Bodycote in a research report on Wednesday. Berenberg Bank restated a “buy” rating and issued a GBX 900 target price on shares of Bodycote in a report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft raised Bodycote to a “buy” rating and raised their target price for the stock from GBX 835 to GBX 960 in a research report on Thursday, May 28th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 842.50.
View Our Latest Stock Report on BOY
Bodycote Stock Performance
Bodycote (LON:BOY – Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported GBX 18.10 earnings per share (EPS) for the quarter. Bodycote had a net margin of 7.55% and a return on equity of 8.58%. On average, equities research analysts expect that Bodycote will post 54.0540541 earnings per share for the current year.
About Bodycote
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Featured Stories
- Five stocks we like better than Bodycote
- Welltower at 52-Week Highs—But Analysts Believe There’s More to Come
- D-Wave’s AT&T Deal Shows Quantum Computing Is Moving Beyond Theory
- Insiders Sell, Institutions Buy: The AI Trade Is Getting More Interesting
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.
